TrialCancer medicine2026

Lenalidomide Plus Dexamethasone as FIRST-Line Therapy in Transplant-Ineligible Patients With Multiple Myeloma: Final Results of the Prospective, Non-Interventional Study FIRST-NIS and Comparison With the FIRST Pivotal Phase III Clinical Trial.

H Nückel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.